menu
    • menu

    Company profile for ILC Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ILC Therapeutics Ltd is an early stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Cancer, Atopic Dermatitis and Psoriasis. Innate Lymphoid Cells were discovered 10 years ago and are split into three classes: ILC-1, ILC-2 and ILC-3, each class associated with a different type of disease: Cancer, Atopic Dermatitis and Psoriasis ...
    ILC Therapeutics Ltd is an early stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Cancer, Atopic Dermatitis and Psoriasis. Innate Lymphoid Cells were discovered 10 years ago and are split into three classes: ILC-1, ILC-2 and ILC-3, each class associated with a different type of disease: Cancer, Atopic Dermatitis and Psoriasis respectively. There is a renaissance of interest in Alpha Interferon driven by the discovery that this protein is the bridge between the two halves of the immune system.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ILC Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Biocity Bo'ness Road, Newhouse, Lanarkshire, Scotland ML1 5UH
    Telephone
    Telephone
    +44 (0) 7403 554048
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ilctherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ILC Therapeutics Announces Successful Completion Of £3.5M Funding Round
    ILC Therapeutics Announces Successful Completion Of £3.5M Funding Round

    06 Sep 2021

    // BIO SPACE

    https://www.biospace.com/article/releases/ilc-therapeutics-announces-successful-completion-of-3-5m-funding-round/?s=80#:~:text=ILC%20Therapeutics%20Announces%20Successful%20Completion%20of%20%C2%A33.5m%20Funding%20Round,-Published%3A%20Sep%2006&text=Funds%20to%20be%20used%20to,strengthened%20with%20three%20new%20appointments.

    BIO SPACE
    06 Sep 2021
    Share Share
    ILC Therapeutics Announces ‘Significant’ COVID-19 Drug Breakthrough
    ILC Therapeutics Announces ‘Significant’ COVID-19 Drug Breakthrough

    07 Oct 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201007005920/en

    BUSINESSWIRE
    07 Oct 2020
    Share Share
    ILC Therapeutics Announces COVID-19 Drug Development
    ILC Therapeutics Announces COVID-19 Drug Development

    06 Oct 2020

    // TECHNOLOGY NETWORK

    https://www.technologynetworks.com/drug-discovery/product-news/ilc-therapeutics-announces-key-covid-19-drug-development-341313

    TECHNOLOGY NETWORK
    06 Oct 2020
    Share Share
    ILC Therapeutics announces research partnership with University of St Andrew
    ILC Therapeutics announces research partnership with University of St Andrew

    22 Jun 2020

    // NEWSMEDICAL

    https://www.news-medical.net/news/20200623/ILC-Therapeutics-announces-research-partnership-with-University-of-St-Andrews-to-fight-against-COVID-19.aspx#:~:text=ILC%20Therapeutics%20announces%20research%20partnership%20with%20University%20of,to%20fight%20against%20COVID%2D19&text=UK%2Dbased%20biotechnology%20firm%20ILC,COVID%2D19%20towards%20clinical%20trials.

    NEWSMEDICAL
    22 Jun 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search